Cargando…

Lesion topographies in multiple sclerosis diagnosis: A reappraisal

OBJECTIVES: To assess the contributions of cortico-juxtacortical and corpus callosum lesions to multiple sclerosis diagnosis and to compare the value of ≥1 vs ≥3 periventricular lesions in clinically isolated syndromes (CIS). METHODS: Step 1: We evaluated lesion topography classifications in 657 pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arrambide, Georgina, Tintore, Mar, Auger, Cristina, Río, Jordi, Castilló, Joaquín, Vidal-Jordana, Angela, Galán, Ingrid, Nos, Carlos, Comabella, Manuel, Mitjana, Raquel, Mulero, Patricia, de Barros, Andrea, Rodríguez-Acevedo, Breogán, Midaglia, Luciana, Sastre-Garriga, Jaume, Rovira, Alex, Montalban, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719929/ https://www.ncbi.nlm.nih.gov/pubmed/29101276 http://dx.doi.org/10.1212/WNL.0000000000004715

Ejemplares similares

Optic Nerve Topography in Multiple Sclerosis Diagnosis: The Utility of Visual Evoked Potentials
por: Vidal-Jordana, Angela, et al.
Publicado: (2021)

Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis
por: Zuluaga, María I., et al.
Publicado: (2019)

Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis
por: Tur, Carmen, et al.
Publicado: (2022)

Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosis
por: Otero-Romero, Susana, et al.
Publicado: (2021)

The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS
por: Tintore, Mar, et al.
Publicado: (2019)

Deciphering multiple sclerosis disability with deep learning attention maps on clinical MRI
por: Coll, Llucia, et al.
Publicado: (2023)

Correction to: Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centre
por: Cobo-Calvo, Alvaro, et al.
Publicado: (2022)

Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment
por: Tur, Carmen, et al.
Publicado: (2013)

Predictive value of early brain atrophy on response in patients treated with interferon β
por: Pérez-Miralles, Francisco Carlos, et al.
Publicado: (2015)

Neurofilament light chain level is a weak risk factor for the development of MS
por: Arrambide, Georgina, et al.
Publicado: (2016)

A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients
por: Carvajal, René, et al.
Publicado: (2023)

Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis
por: Zabalza, Ana, et al.
Publicado: (2022)

T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations
por: Boaventura, Mateus, et al.
Publicado: (2022)

Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis
por: Arrambide, Georgina, et al.
Publicado: (2013)

Diagnostic challenge in children with an acquired demyelinating syndrome: an illustrative case report
por: Midaglia, Luciana, et al.
Publicado: (2023)

Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
por: Malhotra, Sunny, et al.
Publicado: (2015)

Ocrelizumab: a new milestone in multiple sclerosis therapy
por: Mulero, Patricia, et al.
Publicado: (2018)

Fármacos modificadores de la enfermedad en la esclerosis múltiple durante la lactancia: revisión de la evidencia actual
por: Sánchez-Velasco, Sara, et al.
Publicado: (2023)

Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis
por: Cantó, Ester, et al.
Publicado: (2014)

Detection of lesions in the optic nerve with magnetic resonance imaging using a 3D convolutional neural network
por: Martí-Juan, Gerard, et al.
Publicado: (2022)

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
por: Sastre-Garriga, Jaume, et al.
Publicado: (2020)

Aggressive multiple sclerosis (1): Towards a definition of the phenotype
por: Iacobaeus, Ellen, et al.
Publicado: (2020)

Aggressive multiple sclerosis (2): Treatment
por: Arrambide, Georgina, et al.
Publicado: (2020)

Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling
por: Valverde, Sergi, et al.
Publicado: (2015)

Revista de Neurología cumple medio siglo
por: Sastre-Garriga, Jaume
Publicado: (2023)

CSF Chitinase 3–Like 2 Is Associated With Long-term Disability Progression in Patients With Progressive Multiple Sclerosis
por: Comabella, Manuel, et al.
Publicado: (2021)

Multiple sclerosis management during the COVID-19 pandemic
por: Moss, Brandon P, et al.
Publicado: (2020)

Circulating EZH2-positive T cells are decreased in multiple sclerosis patients
por: Malhotra, Sunny, et al.
Publicado: (2018)

MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES
por: Filippi, M., et al.
Publicado: (2016)

Baseline Gene Expression Signatures in Monocytes from Multiple Sclerosis Patients Treated with Interferon-beta
por: Bustamante, Marta F., et al.
Publicado: (2013)

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders
por: Pinteac, Rucsanda, et al.
Publicado: (2020)

Neural bases of reappraisal regulatory effect on negative emotion in high reappraisers☆
por: Zhang, Wencai, et al.
Publicado: (2012)

The role of pontine lesion location in differentiating multiple sclerosis from vascular risk factor-related small vessel disease
por: Geraldes, Ruth, et al.
Publicado: (2020)

Reappraisals in Renaissance thought
por: Nutton, Vivian
Publicado: (1990)

The Role of Cognitive Control in Older Adult Cognitive Reappraisal: Detached and Positive Reappraisal
por: Liang, Ying, et al.
Publicado: (2017)

Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure
por: Malhotra, Sunny, et al.
Publicado: (2023)

Identification of a Novel Risk Locus for Multiple Sclerosis at 13q31.3 by a Pooled Genome-Wide Scan of 500,000 Single Nucleotide Polymorphisms
por: Comabella, Manuel, et al.
Publicado: (2008)

Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
por: Fissolo, Nicolás, et al.
Publicado: (2022)

Reappraising State-Owned Enterprise
por: Amatori, Franco
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_b6m9lqsgn5kmq8tbmg4nhi2n41